Cheongju St. Mary's Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2011
NCT01659775
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Cheongju St. Mary's Hospital, Cheongju, Korea

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis C (Phase 4)

Kidney Failure, Chronic (Phase 4)

Nausea (Phase 4)

Renal Insufficiency (Phase 4)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4